Cargando…

Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study

BACKGROUND: The aim of this study was to investigate the protective role of intranasally administered substance P-loaded gelatin nanoparticles (SP-GNPs) against 6-hydroxydopamine (6-OHDA)-induced apoptosis in vitro and in vivo, and to provide a new strategy for treating brain pathology, such as Park...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Cui-Tao, Jin, Rong-Rong, Jiang, Yi-Na, Lin, Qian, Yu, Wen-Ze, Mao, Kai-Li, Tian, Fu-Rong, Zhao, Ya-Ping, Zhao, Ying-Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396575/ https://www.ncbi.nlm.nih.gov/pubmed/25897205 http://dx.doi.org/10.2147/DDDT.S77237

Ejemplares similares

Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats
por: Zhao, Ying-Zheng, et al.
Publicado: (2016)

Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine
por: Chang, Jui-Chih, et al.
Publicado: (2021)

In Vivo Bio-distribution and Efficient Tumor Targeting of Gelatin/Silica Nanoparticles for Gene Delivery
por: Zhao, Xueqin, et al.
Publicado: (2016)

Cortex Fraxini (Qingpi) Protects Rat Pheochromocytoma Cells against 6-Hydroxydopamine-Induced Apoptosis
por: Li, Jing-Jie, et al.
Publicado: (2015)

Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells
por: Luo, Zihua, et al.
Publicado: (2012)

Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013)

Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics
por: Fatouh, Ahmed M, et al.
Publicado: (2017)

Preparation and Characterization of Gelatin-Based Mucoadhesive Nanocomposites as Intravesical Gene Delivery Scaffolds
por: Liu, Ching-Wen, et al.
Publicado: (2014)

Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis induced by rotenone and 6-hydroxydopamine
por: Peng, Su, et al.
Publicado: (2018)

Human Albumin Prevents 6-Hydroxydopamine-Induced Loss of Tyrosine Hydroxylase in In Vitro and In Vivo
por: Zhang, Li-Juan, et al.
Publicado: (2012)

Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020)

Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery
por: Ahmad, Mohd Zulhelmy, et al.
Publicado: (2022)

Intranasal Delivery of Copper Oxide Nanoparticles Induces Pulmonary Toxicity and Fibrosis in C57BL/6 mice
por: Lai, Xiaofeng, et al.
Publicado: (2018)

Development and characterization of gelatin based nanoparticles for targeted delivery of zidovudine
por: Jadhav, Namdeo R, et al.
Publicado: (2013)

Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA
por: Andrée, Lea, et al.
Publicado: (2022)

Formulation and Optimization of Polymeric Nanoparticles for Intranasal Delivery of Lorazepam Using Box-Behnken Design: In Vitro and In Vivo Evaluation
por: Sharma, Deepak, et al.
Publicado: (2014)

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain
por: Tian, Xin-hua, et al.
Publicado: (2012)

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
por: Tashima, Toshihiko
Publicado: (2020)

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
por: Gagliardi, Mariacristina, et al.
Publicado: (2023)

Biomedical applications of artificial exosomes for intranasal drug delivery
por: Zhao, Jinming, et al.
Publicado: (2023)

Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)

The 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced Neurotoxicity
por: Kao, Chien-Jen, et al.
Publicado: (2017)

Preparation and Characterization of Gelatin and Antioxidant Peptides from Gelatin Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Bone Stimulated by in vitro Gastrointestinal Digestion
por: Yang, Xiu-Rong, et al.
Publicado: (2019)

Gelatin and Antioxidant Peptides from Gelatin Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Scales: Preparation, Identification and Activity Evaluation
por: Qiu, Yi-Ting, et al.
Publicado: (2019)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
por: Liu, Shanshan, et al.
Publicado: (2018)

Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo
por: Zhou, Hefeng, et al.
Publicado: (2019)

Pretreatment With Fragments of Substance-P or With Cholecystokinin Differentially Affects Recovery From Sub-Total Nigrostriatal 6-Hydroxydopamine Lesion
por: Nikolaus, S., et al.
Publicado: (1999)

Highly Efficient Intracellular Protein Delivery by Cationic Polyethyleneimine-Modified Gelatin Nanoparticles
por: Chou, Ming-Ju, et al.
Publicado: (2018)

Nanoparticle delivery systems for substance use disorder
por: Kasina, Vishal, et al.
Publicado: (2022)

Extraction and characterization of gelatin from camel skin (potential halal gelatin) and production of gelatin nanoparticles
por: Ahmed, Mohammed Asif, et al.
Publicado: (2020)

Silver Nanoparticles-Composing Alginate/Gelatine Hydrogel Improves Wound Healing In Vivo
por: Diniz, Flavia Resende, et al.
Publicado: (2020)

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Preparation and characterisation of PHT-loaded chitosan lecithin nanoparticles for intranasal drug delivery to the brain
por: Yousfan, Amal, et al.
Publicado: (2020)

L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
por: Nanaki, Stavroula G., et al.
Publicado: (2022)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress
por: Nourmohammadi, Saeideh, et al.
Publicado: (2022)

Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia
por: Ullah, Irfan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m4srk0tjlj81ci9cfjq6u8rh5c